Jonathan George, DPM
Foot & Ankle Surgery · Saint Charles, MONPI 1700311503
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 42.7% of the total.
Across 154 payments — averaging $107.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Elite Orthopedics, LLC$5K
- Arthrex$4K
- Organogenesis Inc.$247
- Kerecis Limited$155
- Bioventus LLC$125
- plus $239 from 7 others
What the payments were for
- Travel & lodging$5,40833%
- Food & beverage$6,85541%
- Education$4,28226%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 100 | $7,057 |
| Elite Orthopedics, LLC | 31 | $5,196 |
| Arthrex | 9 | $3,525 |
| Organogenesis Inc. | 5 | $247 |
| Kerecis Limited | 1 | $155 |
| Bioventus LLC | 1 | $125 |
| Integra Lifesciences Corporation | 1 | $72 |
| Medtronic | 1 | $70 |
| Paragon 28, Inc. | 1 | $23 |
| Smith+Nephew | 1 | $21 |
| Globus Medical | 1 | $19 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$1,515
- ORTHOLOC 3DI$1,380
- INFINITY$573
- Kerecis Omega3 Marigen$466
- Viaflow$281
- EASYFUSE$161
- Kerecis Omega3 SurgiClose$155
- Kerecis Omega3 GraftGuide$155
- CITREFIX$151
- Exogen Ultrasound Bone Healing System$125
- Puraply Antimicrobial$123
- INCOMPASS TOTAL ANKLE SYSTEM$119
- ORTHOLOC 2 LAPIFUSE$118
- HOFFMANN$114
How this compares
$16,545 in reported general payments places this provider in the 75th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 116 | $3,200 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 29 | $1,375 |
| Cephalexin | 28 | $663 |
| Terbinafine Hcl | 46 | $390 |
| Doxycycline Monohydrate | 15 | $280 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $250 |
| Methylprednisolone | 21 | $138 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Saint Charles
- Daniel AdamovskySaint Charles$8K
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.